Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency.
Information is limited regarding the efficacy of antihypertensive drugs in patients with hypertension associated with renal insufficiency. To address this question, a group of 14 outpatients with essential hypertension and mild renal insufficiency received slow release verapamil 240 mg/day for 14 days after a 4-week washout period. Patients were randomly assigned to a low (4 g/day) or high (11 g/day) salt diet, and crossed over to the alternative diet after 7 days. 24-Hour blood pressure monitoring was performed at the end of the washout period and after 7 and 14 days during verapamil treatment. Verapamil induced a significant fall in mean 24-hour blood pressure that was similar for patients on both diets (p < 0.01). As expected, natriuresis increased significantly during high sodium intake (p < 0.01), and bodyweight fell significantly when sodium intake was reduced (p < 0.05). Meanwhile, serum creatinine and creatinine clearance remained stable. These results indicate that the antihypertensive effect of verapamil is independent of sodium intake even in the presence of mild renal insufficiency.
Ruilope
L M
LM
Hypertensive Unit, 12 de Octubre Hospital, Madrid, Spain.
Casal
M C
MC
Guerrero
L
L
Alcázar
J M
JM
Férnandez
M L
ML
Lahera
V
V
Rodicio
J L
JL
D001794:Blood Pressure / Q000187:drug effects; D003692:Delayed-Action Preparations; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects; D007676:Kidney Failure, Chronic / Q000150:complications*; D012982:Sodium, Dietary / Q000008:administration & dosage / Q000494:pharmacology*; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D012982:Sodium, Dietary; D014700:Verapamil